NEUCA S.A. (WSE:NEU)
796.00
-12.00 (-1.49%)
Jan 21, 2026, 11:54 AM CET
NEUCA Market Cap
NEUCA has a market cap or net worth of 3.64 billion as of January 21, 2026. Its market cap has decreased by -6.74% in one year.
Market Cap
3.64B
Enterprise Value
4.60B
Revenue
13.34B
Ranking
n/a
PE Ratio
23.85
Stock Price
796.00
Market Cap Chart
Since November 22, 2004, NEUCA's market cap has increased from 116.73M to 3.64B, an increase of 3,015.84%. That is a compound annual growth rate of 17.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 20, 2026 | 3.64B | 0.12% |
| Dec 30, 2025 | 3.63B | -6.85% |
| Dec 30, 2024 | 3.90B | -4.37% |
| Dec 29, 2023 | 4.08B | 44.23% |
| Dec 30, 2022 | 2.83B | -23.49% |
| Dec 30, 2021 | 3.70B | 29.38% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Diagnostyka | 6.62B |
| Synektik Spólka Akcyjna | 2.56B |
| Voxel | 1.48B |
| Celon Pharma | 1.14B |
| Selvita | 835.17M |
| Ryvu Therapeutics | 619.62M |
| Centrum Medyczne ENEL-MED | 528.84M |
| Scope Fluidics | 458.77M |